These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3370134)

  • 1. Glucocorticoids amplify glomerular injury in rats with renal ablation.
    García DL; Rennke HG; Brenner BM; Anderson S
    Am J Hypertens; 1988 Jan; 1(1):54-7. PubMed ID: 3370134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation.
    Garcia DL; Rennke HG; Brenner BM; Anderson S
    J Clin Invest; 1987 Sep; 80(3):867-74. PubMed ID: 3040810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic implications of converting-enzyme inhibitors in renal disease.
    Anderson S; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S; Rennke HG; Brenner BM
    J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury.
    Anderson S; Rennke HG; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S242-4. PubMed ID: 3553475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin on the glomerular structure and function of remnant nephrons.
    Ichikawa I; Yoshida Y; Fogo A; Purkerson ML; Klahr S
    Kidney Int; 1988 Nov; 34(5):638-44. PubMed ID: 3199677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.
    Anderson S; Meyer TW; Rennke HG; Brenner BM
    J Clin Invest; 1985 Aug; 76(2):612-9. PubMed ID: 2993362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.
    Fogo A; Yoshida Y; Glick AD; Homma T; Ichikawa I
    J Clin Invest; 1988 Jul; 82(1):322-30. PubMed ID: 3392211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
    Lafayette RA; Mayer G; Park SK; Meyer TW
    J Clin Invest; 1992 Sep; 90(3):766-71. PubMed ID: 1522231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass.
    Garcia DL; Anderson S; Rennke HG; Brenner BM
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6142-6. PubMed ID: 3413082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.
    Tolins JP; Raij L
    Hypertension; 1990 Oct; 16(4):452-61. PubMed ID: 2210813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversing glomerular hypertension stabilizes established glomerular injury in renal ablation.
    Meyer TW; Anderson S; Rennke HG; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S239-41. PubMed ID: 3033177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal functional reserve in the early stage of experimental diabetes.
    De Nicola L; Blantz RC; Gabbai FB
    Diabetes; 1992 Mar; 41(3):267-73. PubMed ID: 1551487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversing glomerular hypertension stabilizes established glomerular injury.
    Meyer TW; Anderson S; Rennke HG; Brenner BM
    Kidney Int; 1987 Mar; 31(3):752-9. PubMed ID: 3033388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat.
    Ploth DW; Rudulph J; LaGrange R; Navar LG
    J Clin Invest; 1979 Nov; 64(5):1325-35. PubMed ID: 227932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of intraglomerular pressure in the initiation and progression of renal disease.
    Anderson S; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S236-8. PubMed ID: 3033176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converting enzyme inhibition prevents postprandial hyperfiltration in rats with renal mass ablation.
    Corman B; Vienet R
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):253S-257S. PubMed ID: 2043314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of glomerular injury or nephron loss in a normotensive rat remnant kidney model.
    Bidani AK; Mitchell KD; Schwartz MM; Navar LG; Lewis EJ
    Kidney Int; 1990 Jul; 38(1):28-38. PubMed ID: 2385084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome.
    Anderson S; Diamond JR; Karnovsky MJ; Brenner BM
    J Clin Invest; 1988 Nov; 82(5):1757-68. PubMed ID: 2846658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.